Supernus Pharmaceuticals Terminates UBS Credit Line Agreement
An SEC filing says Supernus Pharmaceuticals terminated its UBS credit line agreement on October 20, 2026.
An SEC filing says Supernus Pharmaceuticals terminated its UBS credit line agreement on October 20, 2026.